Literature DB >> 16186539

Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS.

E F Goodall1, M J Greenway, I van Marion, C B Carroll, O Hardiman, K E Morrison.   

Abstract

Iron misregulation promotes oxidative stress and abnormally high iron levels have been found in the spinal cords of patients with ALS. The authors investigated whether HFE gene polymorphisms, linked to hemochromatosis, are associated with ALS using two independent populations of patients with sporadic ALS and controls (totaling 379 patients and 400 controls). They found that the H63D polymorphism is overrepresented in individuals with sporadic ALS (odds ratio 1.85, CI: 1.35 to 2.54).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186539     DOI: 10.1212/01.wnl.0000176032.94434.d4

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

Review 1.  Familial Amyotrophic Lateral Sclerosis.

Authors:  Kevin Boylan
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  HFE H63D polymorphism is increased in patients with amyotrophic lateral sclerosis of Italian origin.

Authors:  G Restagno; F Lombardo; P Ghiglione; A Calvo; E Cocco; L Sbaiz; R Mutani; A Chiò
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03       Impact factor: 10.154

3.  HFE p.H63D polymorphism does not influence ALS phenotype and survival.

Authors:  Adriano Chiò; Gabriele Mora; Mario Sabatelli; Claudia Caponnetto; Christian Lunetta; Bryan J Traynor; Janel O Johnson; Mike A Nalls; Andrea Calvo; Cristina Moglia; Giuseppe Borghero; Maria Rosaria Monsurrò; Vincenzo La Bella; Paolo Volanti; Isabella Simone; Fabrizio Salvi; Francesco O Logullo; Riva Nilo; Fabio Giannini; Jessica Mandrioli; Raffaella Tanel; Maria Rita Murru; Paola Mandich; Marcella Zollino; Francesca L Conforti; Silvana Penco; Maura Brunetti; Marco Barberis; Gabriella Restagno
Journal:  Neurobiol Aging       Date:  2015-06-18       Impact factor: 4.673

4.  Superoxide dismutase 1 modulates expression of transferrin receptor.

Authors:  Ruth Danzeisen; Tilmann Achsel; Ulrich Bederke; Mauro Cozzolino; Claudia Crosio; Alberto Ferri; Malte Frenzel; Edith Butler Gralla; Lea Huber; Albert Ludolph; Monica Nencini; Giuseppe Rotilio; Joan Selverstone Valentine; Maria Teresa Carrì
Journal:  J Biol Inorg Chem       Date:  2006-04-26       Impact factor: 3.358

Review 5.  Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges.

Authors:  Giuseppe Marangi; Bryan J Traynor
Journal:  Brain Res       Date:  2014-10-12       Impact factor: 3.252

6.  Mutant HFE H63D protein is associated with prolonged endoplasmic reticulum stress and increased neuronal vulnerability.

Authors:  Yiting Liu; Sang Y Lee; Elizabeth Neely; Wint Nandar; Mthabisi Moyo; Zachary Simmons; James R Connor
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

7.  Increased serum ferritin levels in amyotrophic lateral sclerosis (ALS) patients.

Authors:  E F Goodall; M S Haque; K E Morrison
Journal:  J Neurol       Date:  2008-07-18       Impact factor: 4.849

Review 8.  Targeting angiogenin in therapy of amyotropic lateral sclerosis.

Authors:  Hiroko Kishikawa; David Wu; Guo-fu Hu
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

9.  Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis: the GENEVA study. Rationale, study design and demographic characteristics.

Authors:  Silke Schmidt; Kelli D Allen; Valerie T Loiacono; Barbara Norman; Catherine L Stanwyck; Kristina M Nord; Christina D Williams; Edward J Kasarskis; Freya Kamel; Valerie McGuire; Lorene M Nelson; Eugene Z Oddone
Journal:  Neuroepidemiology       Date:  2008-04-18       Impact factor: 3.282

10.  Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis.

Authors:  Muddasir Qureshi; Robert H Brown; Jack T Rogers; Merit E Cudkowicz
Journal:  Open Neurol J       Date:  2008-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.